ArticleEMBO molecular medicine2026

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

Kristi Buzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.